Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cavα2δ1&NET-IN-3 (example 216) is an inhibitor targeting both the α2δ subunit of voltage-gated calcium channels (VGCC) and the noradrenaline transporter (NET). It exhibits inhibitory constants (Ki) ranging from 100 to 500 nM for the human α2δ-1 subunit of the Ca v 2.2 calcium channel and NET, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,820.00 | |
50 mg | 8-10 weeks | $ 2,380.00 | |
100 mg | 8-10 weeks | $ 3,100.00 |
Description | Cavα2δ1&NET-IN-3 (example 216) is an inhibitor targeting both the α2δ subunit of voltage-gated calcium channels (VGCC) and the noradrenaline transporter (NET). It exhibits inhibitory constants (Ki) ranging from 100 to 500 nM for the human α2δ-1 subunit of the Ca v 2.2 calcium channel and NET, respectively. |
Molecular Weight | 466.6 |
Formula | C24H30N6O2S |
CAS No. | 2143584-82-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cavα2δ1&NET-IN-3 2143584-82-9 inhibitor inhibit